Eduardo A. Guarnera
Research Subjects
Eduardo A. Guarnera has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
A. Franco
Veterinary in Public Health, Faculty of Veterinary Sciences, University of Buenos Aires, Buenos Aires, Argentina
1 shared publicationElizabeth De Souza Neves
<!--label omitted: 4-->Hospital Evandro Chagas-FIOCRUZ,4 Rio de Janeiro, Brazil
1 shared publicationG. Santillan
Departamento de Parasitologı́a Sanitaria, ANLIS ‘Dr. Carlos G. Malbrán. Av. Vélez Sarsfield 563 (1281), Buenos Aires, Argentina
1 shared publicationGloria Griemberg
<!--label omitted: 2-->Immunologı́a Clı́nica, Departamento de Bioquı́mica Clı́nica, Facultad de Farmacia y Bioquı́mica, Hospital de Clı́nicas José de San Martin-UBA,2 Buenos Aires, Argentina, and
1 shared publicationGraciela Santillan
<!--label omitted: 1-->Departamento de Parasitologı́a, ANLIS Dr. Carlos G. Malbran,1 and
1 shared publicationJuan C. Garberi
<!--label omitted: 1-->Departamento de Parasitologı́a, ANLIS Dr. Carlos G. Malbran,1 and
1 shared publication
Latest Publications
- 1 June 2000
- Published by Elsevier in Experimental Parasitology
- Vol. 95 (2) , 122-127
Echinococcus granulosus: DNA Extraction from Germinal Layers Allows Strain Determination in Fertile and Nonfertile Hydatid Cysts
- 1 June 2000
- Published by Elsevier in Experimental Parasitology
- Vol. 95 (2) , 122-127
Echinococcus granulosus: DNA Extraction from Germinal Layers Allows Strain Determination in Fertile and Nonfertile Hydatid Cysts
- 1 February 2000
- Published by Elsevier in Veterinary Parasitology
- Vol. 88 (1-2) , 131-134
Canine echinococcosis: an alternative for surveillance epidemiology
- 1 February 2000
- Published by Elsevier in Veterinary Parasitology
- Vol. 88 (1-2) , 131-134
Canine echinococcosis: an alternative for surveillance epidemiology
- 1 September 1998
- Published by American Society for Microbiology in Clinical and Diagnostic Laboratory Immunology
- Vol. 5 (5) , 627-631
Detection of HumanToxoplasma-Specific Immunoglobulins A, M, and G with a RecombinantToxoplasma gondiiRop2 Protein
TheToxoplasma gondiirhoptry protein Rop2 was expressed inEscherichia colias a fusion protein containing 44 kDa of the 55-kDa mature Rop2, supplied with six histidyl residues at the N-terminal end (Rop2196–561). Humoral response duringToxoplasmainfection of humans was analyzed by immunoglobulin G (IgG), IgA, and IgM enzyme-linked immunosorbent assay with Rop2196–561as the antigen substrate. The analyzed sera were divided according toT. gondii-specific serological tests (IgG, IgA, or IgM indirect immunofluorescence and IgA or IgM immunosorbent agglutination assay) as group A (IgG+IgA−IgM−;n= 35), group B (IgG+IgA+IgM+;n= 21), group C (IgG+IgA+IgM−;n= 5), and group D (IgG+IgA−IgM+;n= 16). Twenty-sixT. gondii-seronegative sera from individuals with other infections were also included (group E). Anti-Rop2 IgG antibodies were detected in 82.8% of group A sera and in 97.6% of the sera with acute-phase marker immunoglobulins (groups B, C, and D). The percentage of IgA antibody reactivity against Rop2196–561was 17.1% in group A, 50% in group D, and 80.8% in groups B and C. The percentage of IgM antibody reactivity was 0% in groups A and C and 62% in groups B and D. Sera from group E failed to show IgA, IgM, or IgG antibody reactivity. SinceT. gondiiRop2 elicits a strong humoral response from an early stage of infection, it is suggested that recombinant Rop2196–561would be suitable for use in diagnostic systems, in combination with otherT. gondiiantigens, to detect specific IgG, IgA, and IgM antibodies.
- 1 September 1998
- Published by American Society for Microbiology in Clinical and Diagnostic Laboratory Immunology
- Vol. 5 (5) , 627-631
Detection of HumanToxoplasma-Specific Immunoglobulins A, M, and G with a RecombinantToxoplasma gondiiRop2 Protein
TheToxoplasma gondiirhoptry protein Rop2 was expressed inEscherichia colias a fusion protein containing 44 kDa of the 55-kDa mature Rop2, supplied with six histidyl residues at the N-terminal end (Rop2196–561). Humoral response duringToxoplasmainfection of humans was analyzed by immunoglobulin G (IgG), IgA, and IgM enzyme-linked immunosorbent assay with Rop2196–561as the antigen substrate. The analyzed sera were divided according toT. gondii-specific serological tests (IgG, IgA, or IgM indirect immunofluorescence and IgA or IgM immunosorbent agglutination assay) as group A (IgG+IgA−IgM−;n= 35), group B (IgG+IgA+IgM+;n= 21), group C (IgG+IgA+IgM−;n= 5), and group D (IgG+IgA−IgM+;n= 16). Twenty-sixT. gondii-seronegative sera from individuals with other infections were also included (group E). Anti-Rop2 IgG antibodies were detected in 82.8% of group A sera and in 97.6% of the sera with acute-phase marker immunoglobulins (groups B, C, and D). The percentage of IgA antibody reactivity against Rop2196–561was 17.1% in group A, 50% in group D, and 80.8% in groups B and C. The percentage of IgM antibody reactivity was 0% in groups A and C and 62% in groups B and D. Sera from group E failed to show IgA, IgM, or IgG antibody reactivity. SinceT. gondiiRop2 elicits a strong humoral response from an early stage of infection, it is suggested that recombinant Rop2196–561would be suitable for use in diagnostic systems, in combination with otherT. gondiiantigens, to detect specific IgG, IgA, and IgM antibodies.